4.35 (0.26%) In connection with its earnings call held on May 26, 2023, Sun Pharmaceutical Industries has informed that Global Ilumya sales for FY23 were US$ 477 million, up by about 51% as compared to FY22.
The above information is a part of company’s filings submitted to BSE.